{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:33:06Z","timestamp":1781350386139,"version":"3.54.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH393"],"award-info":[{"award-number":["ZR2020MH393"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018546","name":"Postdoctoral Innovation Project of Shandong Province","doi-asserted-by":"publisher","award":["202101012"],"award-info":[{"award-number":["202101012"]}],"id":[{"id":"10.13039\/501100018546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.heliyon.2025.e42066","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T13:05:15Z","timestamp":1737205515000},"page":"e42066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic applications of artemisinin in ophthalmic diseases"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-7697","authenticated-orcid":false,"given":"Hao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2025.e42066_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.heliyon.2025.e42066_bib2","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.heliyon.2025.e42066_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104810","article-title":"Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production","volume":"179","author":"Wang","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.751772","article-title":"Immunoregulation by artemisinin and its derivatives: a new role for old antimalarial drugs","volume":"12","author":"Qiu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.apsb.2020.09.001","article-title":"Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics","volume":"11","author":"Dolivo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2025.e42066_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00436-018-6188-9","article-title":"In vitro and in vivo evaluation of six artemisinin derivatives against Schistosoma mansoni","volume":"118","author":"Correa","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib7","first-page":"708","article-title":"Anti-angiogenic and anti-lymphangiogenic role of praziquantel and artemether in experimental mansoniasis","volume":"62","author":"Abd El-Aal","year":"2019","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110062","article-title":"Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion","volume":"365","author":"Lu","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.heliyon.2025.e42066_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pca.2873","article-title":"A review on the latest advances in extraction and analysis of artemisinin","volume":"31","author":"Nahar","year":"2020","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.heliyon.2025.e42066_bib11","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.18240\/ijo.2019.11.20","article-title":"Potential applications of artemisinins in ocular diseases","volume":"12","author":"Lu","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib12","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","article-title":"Artemisinin-derived dimers: potent antimalarial and anticancer agents","volume":"59","author":"Fr\u00f6hlich","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2025.e42066_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107650","article-title":"Traditional application and modern pharmacological research of Artemisia annua L","volume":"216","author":"Feng","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2025.e42066_bib14","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/med.21814","article-title":"Artemisinin-derived dimers from a chemical perspective","volume":"41","author":"Capci","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.heliyon.2025.e42066_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107658","article-title":"The birth of artemisinin","volume":"216","author":"Ma","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2025.e42066_bib16","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1007\/s11033-020-05669-z","article-title":"Artemisinin and its derivatives: a promising cancer therapy","volume":"47","author":"Kiani","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2025.e42066_bib17","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2174\/1389201024666230327082051","article-title":"Recent trends on production sources, biosynthesis pathways and antiviral efficacies of artemisinin: a candidate phytomedicine against SARS-CoV-2","volume":"24","author":"Hussain","year":"2023","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104901","article-title":"Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases","volume":"158","author":"Cheong","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110281","article-title":"Pharmacokinetic study of intravenously administered artemisinin-loaded surface-decorated amphiphilic gamma-cyclodextrin nanoparticles","volume":"106","author":"Gerard Yameogo","year":"2020","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.heliyon.2025.e42066_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.heliyon.2025.e42066_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano9060884","article-title":"Ocular drug delivery: a special focus on the thermosensitive approach","volume":"9","author":"Sapino","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.heliyon.2025.e42066_bib22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2025.e42066_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-020-00745-9","article-title":"Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy","volume":"19","author":"Swetledge","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/13813455.2021.1887266","article-title":"Artesunate alleviates diabetic retinopathy by activating autophagy via the regulation of AMPK\/SIRT1 pathway","volume":"129","author":"Li","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2025.e42066_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym13183038","article-title":"Development and evaluation of polyvinylpyrrolidone K90 and poloxamer 407 self-assembled nanomicelles: enhanced topical ocular delivery of artemisinin","volume":"13","author":"Ponnusamy","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.heliyon.2025.e42066_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fernandez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2025.e42066_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/pharmaceutics14020395","article-title":"Artemisinin-type drugs in tumor cell death: mechanisms, combination treatment with biologics and nanoparticle delivery","volume":"14","author":"Zhou","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2025.e42066_bib28","article-title":"Therapeutical utilization and repurposing of artemisinin and its derivatives: a narrative review","volume":"7","author":"Guan","year":"2023","journal-title":"Adv Biol (Weinh)."},{"key":"10.1016\/j.heliyon.2025.e42066_bib29","article-title":"Artemisinin-derived hybrids and their anticancer activity","volume":"15188","author":"Gao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2025.e42066_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/435713","article-title":"Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives","author":"Shi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.heliyon.2025.e42066_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2017.02.033","article-title":"Cytoprotective effect of kaempferol against palmitic acid-induced pancreatic beta-cell death through modulation of autophagy via AMPK\/mTOR signaling pathway","volume":"448","author":"Varshney","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/ars.2012.5116","article-title":"The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice","volume":"20","author":"Mo","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.heliyon.2025.e42066_bib33","doi-asserted-by":"crossref","first-page":"8775","DOI":"10.1111\/jcmm.16833","article-title":"Artesunate relieves acute kidney injury through inhibiting macrophagic mincle-mediated necroptosis and inflammation to tubular epithelial cell","volume":"25","author":"Lei","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2025.e42066_bib34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbrc.2014.08.009","article-title":"The role of calpain in an in vivo model of oxidative stress-induced retinal ganglion cell damage","volume":"451","author":"Yokoyama","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2025.e42066_bib35","first-page":"21","article-title":"Artemisinin derivatives induce oxidative stress leading to DNA damage and caspase-mediated apoptosis in Theileria annulata-transformed cells","volume":"17","author":"Barman","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.heliyon.2025.e42066_bib36","first-page":"23","article-title":"Novel dihydroartemisinin derivative Mito-DHA5 induces apoptosis associated with mitochondrial pathway in bladder cancer cells","volume":"20","author":"Xiao","year":"2022","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.heliyon.2025.e42066_bib37","first-page":"306","article-title":"Inhibition of artemisinin on oxidative stress injury induced by hydrogen peroxide in human retinal pigment epithelium cells","volume":"39","author":"Xiao-Xu","year":"2019","journal-title":"Rec Adv Ophthalmol"},{"key":"10.1016\/j.heliyon.2025.e42066_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165150","article-title":"Humanin protects RPE cells from endoplasmic reticulum stress-induced apoptosis by upregulation of mitochondrial glutathione","volume":"11","author":"Matsunaga","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2025.e42066_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/1028415X.2017.1284361","article-title":"Current evidence for AMPK activation involvement on resveratrol-induced neuroprotection in cerebral ischemia","volume":"21","author":"Pineda-Ramirez","year":"2018","journal-title":"Nutr. Neurosci."},{"issue":"11","key":"10.1016\/j.heliyon.2025.e42066_bib40","article-title":"Elevated ZNF704 expression is associated with poor prognosis of uveal melanoma and promotes cancer cell growth by regulating AKT\/mTOR signaling","volume":"10","author":"Luo","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib41","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"24","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9911537","article-title":"Artemisinin inhibits the migration and invasion in uveal melanoma via inhibition of the PI3K\/AKT\/mTOR signaling pathway","author":"Farhan","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2025.e42066_bib43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1248\/bpb.b22-00619","article-title":"Artesunate inhibits apoptosis and promotes survival in schwann cells via the PI3K\/AKT\/mTOR axis in diabetic peripheral neuropathy","volume":"46","author":"Zhang","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2025.e42066_bib44","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1074\/jbc.M804491200","article-title":"Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression","volume":"284","author":"Willoughby","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2025.e42066_bib45","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.18240\/ijo.2019.11.20","article-title":"Potential applications of artemisinins in ocular diseases","volume":"12","author":"Lu","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3892\/or.2023.8591","article-title":"Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate-induced decreases in Rb and phosphorylated Rb levels","volume":"50","author":"Okamoto","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2025.e42066_bib47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.lfs.2017.11.008","article-title":"Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells","volume":"192","author":"Im","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00432-024-05711-8","article-title":"Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3\/Akt signaling pathway","volume":"150","author":"Yao","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib49","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.3892\/mmr.2017.7362","article-title":"Effects of artesunate prevent nephritis via the Toll-like receptor 4\/nuclear factor-\u03baB signaling pathway in rats","volume":"16","author":"Wan","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2025.e42066_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2018.10.041","article-title":"Artemisinin B improves learning and memory impairment in AD dementia mice by suppressing neuroinflammation","volume":"395","author":"Qiang","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2025.e42066_bib51","article-title":"Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2025.e42066_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/cmi.2015.13","article-title":"Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL\/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation","volume":"13","author":"Wu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib53","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41401-020-0484-5","article-title":"The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4\/NF-kappaB\/NLRP3 signaling","volume":"42","author":"Yang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2025.e42066_bib54","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1167\/iovs.12-9547","article-title":"Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease","volume":"53","author":"Lee","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cytogfr.2017.11.005","article-title":"Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: current research and future perspectives","volume":"39","author":"Mesquita","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.heliyon.2025.e42066_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175158","article-title":"Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling","volume":"930","author":"Lu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep30843","article-title":"Small molecular-sized artesunate attenuates ocular neovascularization via VEGFR2, PKC\u03b1, and PDGFR Targets","volume":"6","author":"Zong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2025.e42066_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105871","article-title":"Dihydroartemisinin ameliorates retinal vascular dysfunction in diabetes mellitus via the FASN\/Kmal-mTOR\/SREBP1 feedback loop","volume":"174","author":"Gu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib59","article-title":"Novel artemisinin derivative P31 inhibits VEGF-induced corneal neovascularization through AKT and ERK1\/2 pathways","volume":"10","author":"Ding","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2025.e42066_bib60","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1167\/iovs.10-5892","article-title":"Effect of artesunate on endotoxin-induced uveitis in rats","volume":"52","author":"Wang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.redox.2016.06.002","article-title":"Artemisinin protects human retinal pigment epithelial cells from hydrogen peroxide-induced oxidative damage through activation of ERK\/CREB signaling","volume":"9","author":"Chong","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00432-024-05711-8","article-title":"Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3\/Akt signaling pathway","volume":"150","author":"Yao","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib63","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41419-019-2084-1","article-title":"Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2025.e42066_bib64","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/or.2013.2574","article-title":"Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71","volume":"30","author":"Zhao","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2025.e42066_bib65","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fphar.2018.01280","article-title":"Oxidative Stress in Age-Related macular degeneration: Nrf2 as therapeutic target","volume":"9","author":"Bellezza","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib66","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s11357-019-00138-3","article-title":"Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions","volume":"40","author":"Lipecz","year":"2019","journal-title":"Geroscience"},{"key":"10.1016\/j.heliyon.2025.e42066_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2025.e42066_bib68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/postmj\/qgae016","article-title":"Advancements in the treatment of age-related macular degeneration: a comprehensive review","volume":"100","author":"Papaioannou","year":"2024","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.heliyon.2025.e42066_bib69","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1167\/iovs.16-20312","article-title":"Cellular senescence is associated with human retinal microaneurysm formation during aging","volume":"58","author":"Lopez-Luppo","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2025.e42066_bib70","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/acschemneuro.7b00021","article-title":"Artemisinin protects retinal neuronal cells against oxidative stress and restores rat retinal physiological function from light exposed damage","volume":"16","author":"Yan","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yexcr.2016.06.012","article-title":"Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells","volume":"347","author":"Pang","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib72","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib73","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.7150\/ijbs.30536","article-title":"Artemisinin protects human retinal pigmented epithelial cells against hydrogen peroxide-induced oxidative damage by enhancing the activation of AMP-active protein kinase","volume":"15","author":"Li","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib74","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1049\/iet-nbt.2019.0130","article-title":"Design and development of artemisinin and dexamethasone loaded topical nanodispersion for the effective treatment of age-related macular degeneration","volume":"13","author":"Ponnusamy","year":"2019","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/jop.2022.0133","article-title":"Anti-inflammatories in the treatment of dry eye disease: a review","volume":"39","author":"Perez","year":"2023","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.heliyon.2025.e42066_bib76","article-title":"Dry eye disease management","volume":"25","author":"Safir","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2025.e42066_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.heliyon.2025.e42066_bib78","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1167\/iovs.17-23397","article-title":"MyD88 deficiency protects against dry eye-induced damage","volume":"59","author":"Reins","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/srep38115","article-title":"Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells","volume":"6","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2025.e42066_bib80","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/aps.2017.185","article-title":"Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages","volume":"39","author":"Yan","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2025.e42066_bib81","article-title":"Diabetic retinopathy: looking forward to 2030","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib82","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.TR120000981","article-title":"Lipid metabolism dysregulation in diabetic retinopathy","volume":"62","author":"Busik","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3945\/ajcn.117.153825","article-title":"Omega-3 and omega-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases","volume":"106","author":"Gong","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.heliyon.2025.e42066_bib84","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.freeradbiomed.2018.10.419","article-title":"Oxidative stress mediated by lipid metabolism contributes to high glucose-induced senescence in retinal pigment epithelium","volume":"130","author":"Chen","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2025.e42066_bib85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2022.06.226","article-title":"Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2","volume":"188","author":"Bathish","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e42066_bib86","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1248\/bpb.b17-00475","article-title":"Mammalian target of rapamycin (mTOR) as a potential therapeutic target in pathological ocular angiogenesis","volume":"40","author":"Nakahara","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2025.e42066_bib87","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/jmf.2016.3891","article-title":"Aralia elata (Miq) seem extract decreases O-GlcNAc transferase expression and retinal cell death in diabetic mice","volume":"20","author":"Kim","year":"2017","journal-title":"J. Med. Food"},{"key":"10.1016\/j.heliyon.2025.e42066_bib88","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.1016\/j.dsx.2017.03.034","article-title":"Correlation of various serum biomarkers with the severity of diabetic retinopathy","volume":"11","author":"Nalini","year":"2017","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.heliyon.2025.e42066_bib89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08977194.2018.1477140","article-title":"Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases","volume":"36","author":"Mesquita","year":"2018","journal-title":"Growth Factors"},{"key":"10.1016\/j.heliyon.2025.e42066_bib90","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/13813455.2021.1887266","article-title":"LChen, Artesunate alleviates diabetic retinopathy by activating autophagy via the regulation of AMPK\/SIRT1 pathway","volume":"129","author":"Li","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2025.e42066_bib91","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/17425247.2017.1343297","article-title":"Modulating release of ranibizumab and aflibercept from thiolated chitosan-based hydrogels for potential treatment of ocular neovascularization","volume":"14","author":"Moreno","year":"2017","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.heliyon.2025.e42066_bib92","doi-asserted-by":"crossref","first-page":"208","DOI":"10.15252\/emmm.201505613","article-title":"Increased VEGF-A promotes multiple distinct aging diseases of the eye through shared pathomechanisms","volume":"6","author":"Marneros","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.heliyon.2025.e42066_bib93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/jop.2018.0097","article-title":"A pilot clinical study of intravitreal injection of artesunate for ocular neovascularization","volume":"35","author":"Li","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.heliyon.2025.e42066_bib94","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ceo.14214","article-title":"Current management of uveal melanoma: a review","volume":"51","author":"Bai","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib95","first-page":"3","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting the PI3K pathway in cancer: are we making headway?","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CMR.0b013e32832ccd09","article-title":"Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma","volume":"20","author":"Populo","year":"2010","journal-title":"Melanoma Res."},{"key":"10.1016\/j.heliyon.2025.e42066_bib98","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fphar.2016.00395","article-title":"Judicious toggling of mTOR activity to combat insulin resistance and cancer: current evidence and perspectives","volume":"7","author":"Ong","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib99","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/1568009618666180425142653","article-title":"The anti-malarial drug artesunate blocks wnt\/\u03b2-catenin pathway and inhibits growth, migration and invasion of uveal melanoma cells","volume":"18","author":"Zheng","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.heliyon.2025.e42066_bib100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1167\/iovs.09-3974","article-title":"The PI3K\/Akt and mTOR\/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf\/ERK","volume":"51","author":"Babchia","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2025.e42066_bib101","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/1568009618666180425142653","article-title":"The anti-malarial drug artesunate blocks Wnt\/beta-catenin pathway and inhibits growth, migration and invasion of uveal melanoma cells","volume":"18","author":"Zheng","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.heliyon.2025.e42066_bib102","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41433-022-01980-0","article-title":"Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact","volume":"37","author":"Shields","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.heliyon.2025.e42066_bib103","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10571-013-9973-0","article-title":"Neuroprotective potential of bacopa monnieri and bacoside a against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats","volume":"33","author":"Thomas","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib104","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamaoncol.2019.6716","article-title":"Global retinoblastoma presentation and analysis by national income level","volume":"6","author":"Global Retinoblastoma Study","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-2007-967138","article-title":"Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside","volume":"73","author":"Efferth","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.heliyon.2025.e42066_bib106","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1002\/med.21837","article-title":"Recent pharmacological advances in the repurposing of artemisinin drugs","volume":"41","author":"Meng","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.heliyon.2025.e42066_bib107","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fcimb.2018.00256","article-title":"Artemisinin derivatives and synthetic trioxane trigger apoptotic cell death in asexual stages of plasmodium","volume":"8","author":"Gunjan","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib108","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3892\/or.2023.8591","article-title":"Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate-induced decreases in Rb and phosphorylated Rb levels","volume":"50","author":"Okamoto","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2025.e42066_bib109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41435-022-00168-6","article-title":"Progress in the genetics of uveitis","volume":"23","author":"Huang","year":"2022","journal-title":"Gene Immun."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e42066_bib110","article-title":"Uveitis: molecular pathogenesis and emerging therapies","volume":"30","author":"Egwuagu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib111","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s42003-019-0563-7","article-title":"Adipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nuts","volume":"2","author":"Aquilano","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.heliyon.2025.e42066_bib112","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00347-024-02084-8","article-title":"Uveitis und multiple Sklerose : Klinik, Diagnostik, Management und Therapie [Uveitis and multiple sclerosis : Clinical aspects, diagnostics, management and treatment]","volume":"121","author":"St\u00fcbiger","year":"2024","journal-title":"Ophthalmologie"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025004463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025004463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:01:56Z","timestamp":1769032916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844025004463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2405844025004463"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42066","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic applications of artemisinin in ophthalmic diseases","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e42066"}}